Ropes & Gray Represents Synageva in $117 Million Stock Offering

In The News
January 9, 2013
A team of Ropes & Gray attorneys advised Synageva BioPharma Corp. on the company’s offering of 2,472,500 shares of its common stock at a price of $47.53 per share, closed on January 9th. Synageva is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

The Ropes & Gray team was led by securities & public companies partner Paul Kinsella, and included securities & public companies associates Zach Blume and paralegal Drew Fishback.